New drug delays progression of glioma, a deadly brain cancer: Study is first clinical trial…
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible…